Nie, Shulun
Zhu, Yufang
Yang, Jia
Xin, Tao
Xue, Song
Zhang, Xianbin
Sun, Jujie
Mu, Dianbin
Gao, Yongsheng
Chen, Zhaoqiu
Ding, Xingchen
Yu, Jinming
Funding for this research was provided by:
National Key Research and Development Program of China (2018YFE0114100)
Key Technology Research and Development Program of Shandong (2019GGX101057)
Science Technology Program of Jinan (201805051)
Article History
Received: 31 January 2021
Accepted: 10 May 2021
First Online: 7 June 2021
Declarations
:
: The trial was registered with Chinese Clinical Trial Registry (ChiCTR2100046106). This study was approved by the institutional review board of Shandong Cancer Hospital and Institute. All patients provided written informed consent to participate in the study.
: Not applicable.
: The authors declare that they have no competing interests.